EDESA BIOTECH, INC. (EDSA)

Every figure this model derived for EDSA, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2021-09-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2023-09-30
cash 10,799,790 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 10,780,278 AssetsCurrent 2026-06-30
current liabilities 3,910,041 LiabilitiesCurrent 2026-06-30
equity 8,811,154 StockholdersEquity 2026-06-30
revenue 0 Revenues 2021-09-30
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up EDSA on one particular measure came for.

RatioValue
current ratio2.76
current ratio reported2.76
revenue growth-100.0
revenue growth per share-100.0

What to be careful about

What this model itself distrusts about EDSA's figures. Written by the derivation as it ran, not added afterwards.